- Yidu Technology's stock fell 12.78% this week to close at 2.32 HKD, underperforming the Hang Seng Index and twice hitting historical lows amid increased volatility.
- Key corporate developments included winning a smart healthcare project bid at Tongji Hospital and releasing governance updates alongside preparations for its 2027 interim results.
- Institutional analysts maintained a strong buy consensus with an average target price of 8.94 HKD, while upcoming fiscal half-year reports will provide critical fundamental validation.
- Yidu Tech scheduled a board meeting for Nov. 22, 2026.
- The meeting will review the unaudited interim results for the 6 months ended Sept. 30, 2026.
- The board will also discuss the potential distribution of an interim dividend.
- Yidu Tech announced its updated board of directors and committee members effective Nov. 11, 2026.
- Gong Yingying serves as Chair, while Xu Jiming acts as CEO and Feng Xiaoying joins as an executive director alongside independent non-executive directors.
- Pan Rongrong, Fan Wenhui, and Zhang Linqi lead the specialized audit, remuneration, and nomination committees respectively.
- Yidu Tech appointed Fan Wenhui as an independent non-executive director effective November 11, 2026, replacing Ma Wei-Ying.
- Fan succeeds Ma as the remuneration committee chair and serves as a member of both the audit and nomination committees.
- Fan has served as a professor at Tsinghua University since December 2012, specializing in computer simulation and artificial intelligence.
- Yidu Technology experienced a cumulative decline of 2.21 % to close at 2.88 HKD this week, accompanied by low trading volume.
- Institutional coverage remains strongly positive with a consensus buy rating and a target price of 8.94 HKD, despite weak short-term price performance and capital participation.
- The company will release its fiscal year 2027 interim financial report on November 25, which will serve as a key test for market expectations.
- Yidu Cloud (Beijing) Technology, an affiliate of Yidu Tech, secured the next-generation big data platform project for the First Affiliated Hospital of Chongqing Medical University.
- The contract is valued at approximately RMB 13.29 million, as announced on October 26, 2026.
- The project details were disclosed via the Hong Kong Stock Exchange regulatory system on the same date.
- Yidu Tech closed at 2.88 HKD this week, marking a slight increase of 0.35 % and outperforming the Hang Seng Index.
- Two covering institutions gave a consensus strong buy rating with a target price of 8.94 HKD, representing a 210.48 % premium over the current price.
- The upcoming highlight for next week is the release of the company's fiscal year 2027 interim financial results scheduled for November 25, 2026.